Exela Pharma Sciences LLC recalls Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL)
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of Particulate Matter: Silicone
- Products
-
- Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL)
- Company
- Exela Pharma Sciences LLC
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 23,425 vials
- About this recall
- Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mL (1mg/mL), 100 mL Single-Dose Vial, 25 count carton, Ready to Use For Intravenous Infusion Only Preservative Free, Rx Only, Manufactured and Distributed by Exela Pharma Sciences, LLC, Lenoir, NC 28645, (Vial NDC 51754-2131-1; Carton NDC 51754-2131-4).